Xilio Therapeutics, Inc. - Common Stock — 분기별 재무제표 (NASDAQ:XLO) | MetaTrader

전체 차트 열기 Full chart

뉴스

Cancer Stocks That Are Advancing the Future of Oncology Care

Xilio Therapeutics, Inc. (XLO) Reports Q1 Loss, Beats Revenue Estimates

Opus Genetics, Inc. (IRD) Reports Q1 Loss, Misses Revenue Estimates

Oculis Holding AG (OCS) Reports Q1 Loss, Lags Revenue Estimates

Cancer Stocks to Buy as Innovation Reshapes Global Oncology Market

Xilio Therapeutics, 14대 1 주식 병합 결정

Xilio Therapeutics implements 1-for-14 reverse stock split

Xilio Therapeutics secures $35.8 million from warrant exercises

Xilio 테라퓨틱스, 시리즈 B 워런트 행사로 3580만 달러 조달

Xilio Development Q3 실적 에상치보다 저조, 수익 예상치를 넘어

Xilio Development earnings missed by $0.06, revenue topped estimates

Xilio Therapeutics, Inc. (XLO) Reports Q3 Loss, Misses Revenue Estimates